Advertisement

Topics

UGN-101 Shows Encouraging CR Rates in Urothelial Cancer

14:45 EST 8 Jan 2019 | OncLive

The investigational mitomycin formulation UGN-101 demonstrated a 57% complete response rate in patients with low-grade upper-tract urothelial cancer.

Original Article: UGN-101 Shows Encouraging CR Rates in Urothelial Cancer

NEXT ARTICLE

More From BioPortfolio on "UGN-101 Shows Encouraging CR Rates in Urothelial Cancer"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...